Latest Utilities News

Etherstack’s subsidiary Auria Wireless has landed a A$0.8 million contract to upgrade Energy Queensland’s statewide digital radio network, continuing a partnership that dates back over a decade.

Tivan Limited has agreed to acquire full ownership of the Molyhil Tungsten-Molybdenum Project, positioning itself at the forefront of critical minerals development in Australia's Northern Territory. This strategic move complements its adjacent Sandover Fluorite Project, promising operational synergies and accelerated growth.

Eclipse Metals has launched a significant drilling campaign in Greenland, targeting rare earth elements at its Ivigtût and Grønnedal sites amid rising global demand for critical minerals.

Metallium Limited and Ucore Rare Metals have entered a binding 12-month collaboration to integrate their cutting-edge technologies, aiming to establish the first fully U.S.-based rare earth element refining pathway and reduce reliance on Chinese supply chains.

Mercury NZ Limited confirms the share allotment price for its Dividend Reinvestment Plan and details its upcoming dividend payment scheduled for 30 September 2025.

Medicare contractor Novitas plans to convene an expert panel in early 2026 to review coverage for Pacific Edge’s Cxbladder Triage test following the 2025 update to the American Urological Association microhematuria guideline.

Altair Minerals has successfully navigated the initial legal hearing against BHP over the contested use of its Olympic Domain Project area, setting the stage for a protracted dispute over exploration rights and project valuation.

Evolution Energy Minerals has successfully closed an oversubscribed rights issue, raising $1.45 million and topping up with an additional $300,000 placement to fund key graphite and copper projects.

Core Lithium has significantly increased its Ore Reserve Estimate at the Finniss Lithium Project, with the Carlton deposit upgrade driving a 42% rise in total reserves. This milestone strengthens the project's restart schedule and expansion potential.

dorsaVi has inked a five-year sales agreement with Select Medical, opening access to over 1,900 US outpatient physical therapy centers for its FDA-approved motion analysis products. This follows a successful 18-month pilot validating clinical benefits in athlete rehabilitation.

Briscoe Group Limited reported a near-flat half-year sales performance with a modest decline in net profit, while advancing key strategic investments including a new distribution centre. The company declared a 10-cent interim dividend amid cautious economic outlook.

Artrya Limited has raised A$75 million through a two-tranche placement and launched a A$5 million share purchase plan to fast-track the U.S. commercialisation of its AI-powered Salix platform following FDA clearance.